Pharma Team | ||||||||||||||
| Player | Week Conference | Rank | Fantasy | Availability | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Opp | Proj | Actual | 2025 | Last 1 | Last 3 | Last 5 | Season | Status | |||||
QB CIN (10) | — | — | 29 | 34.06 | 42.77↑ | 34.21 | 27.4 219.44 Total | Locked | QB | |||||
RB PHI (9) | — | — | 71 | 27.95↑ | 14.68 | 10.59 | 7.3 109.75 Total | Locked | RB | |||||
RB KC (10) | — | — | 54 | 11.15 | 12.98 | 9.16 | 9.1 154.55 Total | Locked | RB/TE | |||||
RB JAC (8) | — | — | 74 | 8.25↑ | 8.37↑ | 7.47 | 6.5 103.9 Total | Locked | RB/WR/TE | |||||
WR KC (10) | — | — | 52 | 16.6↑ | 8.38 | 8.9 | 11.6 186 Total | Locked | WR | |||||
WR GB (5) | — | — | 103 | 1.8↓ | 2.82↓ | 10.54 | 7.8 100.85 Total | Locked | WR/CB | |||||
WR CAR (14) | — | — | 151 | 3.1↓ | 4.45 | 3.99 | 4.6 46.15 Total | Locked | RB/WR/TE/CB | |||||
WR KC (10) | — | — | 212 | 2.85↓ | 3.95 | 3.95 | 4 7.9 Total | Locked | QB/RB/WR/TE | |||||
TE DAL (10) | — | — | 67 | 4.45 | 6.05↑ | 4.64 | 3.6 50.15 Total | Locked | TE | |||||
K DEN (12) | — | — | 19 | 19↑ | 13.67 | 11.2 | 11.3 192 Total | Locked | K/P | |||||
D/ST KC (10) | — | — | 15 | 23↑ | 14.01 | 14.27 | 12.4 211.02 Total | Locked | P/D/ST | |||||
| K/D/ST | ||||||||||||||
Benched | ||||||||||||||
QB CLE (9) | — | — | 40 | -0.45↓ | 4.23↓ | 10.42 | 11 110.43 Total | Locked | BN | |||||
RB SF (14) | — | — | 130 | 0.05↓ | 0.03↓ | 1.2 | 1.8 14.2 Total | Locked | BN | |||||
WR ATL (5) | — | — | 27 | 21.7 | 9.67↓ | 18.76 | 23.7 284.7 Total | Locked | BN | |||||
WR NYG (14) | — | — | 113 | 4.8↓ | 22.78 | 22.21 | 22.2 88.85 Total | Locked | BN | |||||
TE CAR (14) | — | — | 54 | 3.05↓ | 4.52 | 4.01 | 5 70.6 Total | Locked | BN | |||||
K NYG (14) | — | — | 37 | 7↓ | 8.33 | 11.4 | 11.4 57 Total | Locked | BN | |||||
P FA | — | — | 36 | 10.9 | 10.9 | 10.9 | 10.9 10.9 Total | Locked | BN | |||||
| BN | ||||||||||||||
| BN | ||||||||||||||
| BN | ||||||||||||||
| BN | ||||||||||||||
| BN | ||||||||||||||
| BN | ||||||||||||||
| BN | ||||||||||||||
| BN | ||||||||||||||
| BN | ||||||||||||||
| BN | ||||||||||||||
| BN | ||||||||||||||
